Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Journal for Immunotherapy of Cancer
|
October 31, 2020
CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferation
Anna Christina Dragon, Katharina Zimmermann, Thomas Nerreter, et al.
HLA
|
June 26, 2024
Engineered HCMV-infected APCs enable the identification of new immunodominant HLA-restricted epitopes of anti-HCMV T-cell immunity
Maria Michela Santamorena, Sabine Tischer-Zimmermann, Agnes Bonifacius, et al.
Molecular Therapy. Oncology
|
July 13, 2026
Next-generation LMP2A-targeting TCR-recombinant T cells with inducible IL-18 expression to treat EBV-associated malignancies
Agnes Bonifacius, Philip Mausberg, Friederike Floegel, et al.
Plos Pathogens
|
September 26, 2024
DNA methylation profiling identifies TBKBP1 as potent amplifier of cytotoxic activity in CMV-specific human CD8+ T cells
Zheng Yu, Varun Sasidharan-Nair, Thalea Buchta, et al.
Frontiers in Immunology
|
November 2, 2023
CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors
Anna Christina Dragon, Luca Marie Beermann, Melina Umland, et al.
Plos Pathogens
|
March 1, 2021
Correction: Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMV
Sebastian J Theobald, Christoph Kreer, Sahamoddin Khailaie, et al.
JAMA Neurology
|
October 7, 2024
Directly Isolated Allogeneic Virus-Specific T Cells in Progressive Multifocal Leukoencephalopathy
Nora Möhn, Lea Grote-Levi, Mike P Wattjes, et al.
Plos Pathogens
|
July 16, 2020
Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMV
Sebastian J Theobald, Christoph Kreer, Sahamoddin Khailaie, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 16, 2025
Targeting BCL11B in CAR-engineered lymphoid progenitors drives NK-like cell development with prolonged anti-leukemic activity
Franziska Baatz, Arnab Ghosh, Jessica Herbst, et al.
Frontiers in Bioengineering and Biotechnology
|
April 28, 2022
Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell Therapy
Agnes Bonifacius, Sabine Tischer-Zimmermann, Maria Michela Santamorena, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Journal for Immunotherapy of Cancer
|
October 31, 2020
CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferation
Anna Christina Dragon, Katharina Zimmermann, Thomas Nerreter, et al.
HLA
|
June 26, 2024
Engineered HCMV-infected APCs enable the identification of new immunodominant HLA-restricted epitopes of anti-HCMV T-cell immunity
Maria Michela Santamorena, Sabine Tischer-Zimmermann, Agnes Bonifacius, et al.
Molecular Therapy. Oncology
|
July 13, 2026
Next-generation LMP2A-targeting TCR-recombinant T cells with inducible IL-18 expression to treat EBV-associated malignancies
Agnes Bonifacius, Philip Mausberg, Friederike Floegel, et al.
Plos Pathogens
|
September 26, 2024
DNA methylation profiling identifies TBKBP1 as potent amplifier of cytotoxic activity in CMV-specific human CD8+ T cells
Zheng Yu, Varun Sasidharan-Nair, Thalea Buchta, et al.
Frontiers in Immunology
|
November 2, 2023
CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors
Anna Christina Dragon, Luca Marie Beermann, Melina Umland, et al.
Plos Pathogens
|
March 1, 2021
Correction: Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMV
Sebastian J Theobald, Christoph Kreer, Sahamoddin Khailaie, et al.
JAMA Neurology
|
October 7, 2024
Directly Isolated Allogeneic Virus-Specific T Cells in Progressive Multifocal Leukoencephalopathy
Nora Möhn, Lea Grote-Levi, Mike P Wattjes, et al.
Plos Pathogens
|
July 16, 2020
Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMV
Sebastian J Theobald, Christoph Kreer, Sahamoddin Khailaie, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 16, 2025
Targeting BCL11B in CAR-engineered lymphoid progenitors drives NK-like cell development with prolonged anti-leukemic activity
Franziska Baatz, Arnab Ghosh, Jessica Herbst, et al.
Frontiers in Bioengineering and Biotechnology
|
April 28, 2022
Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell Therapy
Agnes Bonifacius, Sabine Tischer-Zimmermann, Maria Michela Santamorena, et al.
Page
of 4